MatriSys Bioscience
PrivateLast Round
Series A
Jul 15, 2022
Total Funding Raised
$14.5M
Company Overview
MatriSys Bioscience is a biotechnology company that develops microbiome-based therapeutics for the treatment of chronic skin diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MatriSys Bioscience Comparables
Compare MatriSys Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AOBiome Therapeutics Inc. | 88% | |
| Alphyn Biologics, Inc. | 82% | |
| ResVita Bio | 81% |
MatriSys Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 15, 2022 | ||||
| Debt | Mar 11, 2021 | ||||
| VC Round | Mar 11, 2021 | ||||
| Convertible Debt | Jan 5, 2017 |
MatriSys Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | VC Round |
| Mesa Verde Venture Partners | VC Round, Series A |
| ALMA Life Sciences | Series A |
| TCA Venture Group | Series A, Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 2, 2026
Monthly visitors increased 63% MoM.
- Nov 6, 2025
Monthly visitors increased 277% MoM.
MatriSys Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about MatriSys Bioscience's valuation, stock price, and market status.
Is MatriSys Bioscience a public or private company?
MatriSys Bioscience is a private company.
What is the current stock price of MatriSys Bioscience?
MatriSys Bioscience is a private company with no public stock price. No recent secondary market data is available.
How much is MatriSys Bioscience worth (valuation)?
Valuation information for MatriSys Bioscience is not publicly available.
Can I buy MatriSys Bioscience stock?
MatriSys Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was MatriSys Bioscience's last funding round?
MatriSys Bioscience's most recent funding round was Debt on March 11, 2021.
Who are the main investors in MatriSys Bioscience?
Key investors in MatriSys Bioscience include National Institute of Allergy and Infectious Diseases, TCA Venture Group.
Will MatriSys Bioscience IPO soon?
No public IPO plans have been announced for MatriSys Bioscience.
How can I track MatriSys Bioscience secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MatriSys Bioscience's secondary market activity and sign up for updates.